Navigation Links
P.A.C.K. Week Declared in Support of Fruits & Veggies-More Matters Month
Date:9/13/2007

n exciting initiative that helps children and parents appreciate the benefits of adding more fruits and vegetables to their diets, and shows them how easy it can be when all forms, including 100% juice, are considered."

Fruits & Veggies-More Matters is a national health call-to-action aimed at increasing Americans' fruit and vegetable consumption by inspiring and helping them include more fruits and vegetables into their daily diets. Welch's is an active member of Produce for Better Health Foundation, and is committed to helping Americans eat more fruit by providing wholesome and delicious fruit- based solutions to families.

For more information and tips on how to participate in P.A.C.K. Week, visit http://www.welchs.com. For more information about Fruits & Veggies-More Matters, visit http://www.fruitsandveggiesmorematters.org.

Editor's Note

B-roll footage in support of P.A.C.K. Week will be fed via satellite on:

-- Friday, September 21, 2007, 2:30 to 3:00 PM EST

-- Saturday, September 22, 2007, 3:30 AM to 4:00 AM EST

-- Sunday, September 23, 2007, 3:30 AM to 4:00 AM EST

-- Monday, September 24, 2007, 3:30 AM to 4:00 AM EST

Galaxy 26/TR 17; C-band analog; Download Frequency: 4040 (V); Orbital Slot: 93 degrees west Audios: 6.2 and 6.8 full program mix

For b-roll troubleshooting questions, contact 617-340-4300.


'/>"/>
SOURCE Welch's
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. BC farms declared free of bird flu
2. Passive smoking declared as Toxic in California
3. India Declared Free of Rinderpest Cattle Infection
4. Miracle Boy Prince Declared Fit by Medical Team
5. RMIT Business School Building Declared Safe
6. Surat Declared Free of Hantavirus
7. Death in Illinois ER declared Homicide
8. A million Pound Public consultation - declared a sham!!
9. Arthritis drugs safer than previously declared
10. Legal ‘high’ Drugs Declared Illegl
11. Haryana Declared Neonatal Tetanus-free
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...of local dance students will dance to raise money ...OLIS, Jan. 8 , , , WHO: ...l show off their talent in the 3rd annual Dance, ... Dance Arts Centre. The, event wi...r., Participants raise money thr...
(Date:1/8/2009)...ounced Acquisition in 2009 Continues Growth Trend ...-FirstCall/ -- IPC The Hospitalist Company, Inc. (...hysician group practice company, announced today t...dwest Acute Care Consultants, Inc. (MACC) in St. L...ed expansion in the St. Louis market, where IPC ha...
(Date:1/8/2009)...N, Jan. 8 The Pew Chari...s been named director, chemical and food safety pr...program. Olson, who was formerly deputy staff dire...n Environment and Public Works, brings nearly 25 y...sumer advocacy to Pew. , , "We are excited to ...
(Date:1/8/2009)...a., Jan. 8 Cephalon, In...aldino, Jr., Ph.D., Chairman and CEO will present...eld on January 13, 2009 in San Francisco, CA at ap... Time). The presentation will be webcast live on t...site. , , The webcast will be archived for one...
Breaking Medicine News(10 mins):Health News:Dance With Courage to Benefit Camp Courage 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
...ns, polio is a disease from the past, a successful...oks.// But around the globe it’s a different story...s arguably the greatest-ever act in the name of th...f coordinated effort by millions of healthcare wor...
...the Johns Hopkins Bloomberg School of Public Healt...w test for detecting //the malaria parasite in hum...t for determining treatment, the method could pote...demiological studies where large-scale malaria scr...
...stino SJ, a Jesuit priest, well-known for his care...way on Monday at the age of 80. He was the MD, fou...ome, a centre for abandoned HIV-positive children....f People for Peace in Africa, paid the following t...
...dical workforce should be a key component of healt...the Victorian state//election, according to the Au...rkforce problems do not end with the opening of ne...’ said AMSA President, Teresa Cosgriff. ‘These stu...
Other Medicine News:Health News:Global Polio Eradication: A Campaign to Vaccinate Every Child on the Planet 2Health News:Safer Method for Large-Scale Malaria Screening Developed 2Health News:Prioritise Doctor Training in Election Health Promises: AMSA 2
(Date:1/8/2009)... treated at the initial dose in an ongoing Phase I... decline after three days , , Conference Call T...wswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. ... first cohort of an ongoing Phase Ib clinical tria...leoside polymerase inhibitor. ANA598 was very wel...
(Date:1/7/2009)...K, Md., Jan. 7 ImQuest Life Scienc... IND application to the Food and Drug Administrati...d pyrimidinedione HIV inhibitor IQP-0410. ImQuest ...e first quarter of 2009. IQP-0410 is a novel small... a nonnucleoside reverse transcriptase inhibitor (...
(Date:1/6/2009)...Expands on Successful Results from prior U.S., U.K...swire/ -- Vital Therapies, Inc. (VTI), a developme...nounced patient enrollment has begun for a randomi...ial that will study the Extracorporeal Liver Assis...cute Liver Failure (ALF) under three protocols. Th...
(Date:1/6/2009)...E, Md., Jan. 6 Sequella... focused on diseases of epidemic potential, announ...the treatment of tuberculosis (TB), was the first ...inical program contract to Dynport Vaccine Company...arded by the National Institute of Allergy and Inf...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Aspreva receives final court approval for acquisition by Galenica 8509 1Aspreva receives final court approval for acquisition by Galenica 8509 2Aspreva receives final court approval for acquisition by Galenica 8509 3Aspreva receives final court approval for acquisition by Galenica 8509 4Alsius Corporation Announces Program for Early Exercise of Warrants 8507 1Alsius Corporation Announces Program for Early Exercise of Warrants 8507 2Alsius Corporation Announces Program for Early Exercise of Warrants 8507 3Alsius Corporation Announces Program for Early Exercise of Warrants 8507 4New neuroimaging study identifies brain signature for cigarette cravings 8506 1New neuroimaging study identifies brain signature for cigarette cravings 8506 2Cumberland Pharmaceuticals Announces Appointments 8504 1Cumberland Pharmaceuticals Announces Appointments 8504 2
...SCO confirm safety findings,and demonstrate clinic...ectal and other types of cancer., PRINCETON, N.J.,...cals announced positive safety and efficacy result...Floxuridine), Liposome,Injection in patients with ...s were presented yesterday in a poster presentatio...
...(CSE: GEN) announced,today pre-clinical data illus...umab) antibody may have broad potential,to treat c...idermal,growth factor receptor). , Recently, mutat...f EGFr have been identified in tumors from lung ca...ctor in the potential success of,EGFr-directed tre...
Other Medicine Technology:Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 2Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 3
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: